Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$278.73 - $327.27 $51.9 Million - $60.9 Million
-186,161 Reduced 41.37%
263,870 $85.6 Million
Q1 2022

May 03, 2022

SELL
$234.69 - $291.66 $1.11 Million - $1.38 Million
-4,732 Reduced 1.04%
450,031 $129 Million
Q4 2021

Feb 10, 2022

SELL
$224.85 - $279.04 $7.93 Million - $9.84 Million
-35,263 Reduced 7.2%
454,763 $126 Million
Q3 2021

Nov 05, 2021

SELL
$221.6 - $272.71 $2.1 Million - $2.59 Million
-9,483 Reduced 1.9%
490,026 $113 Million
Q2 2021

Aug 04, 2021

BUY
$180.55 - $233.54 $7.08 Million - $9.16 Million
39,229 Added 8.52%
499,509 $115 Million
Q1 2021

May 10, 2021

BUY
$164.32 - $212.72 $53.5 Million - $69.2 Million
325,310 Added 241.02%
460,280 $86 Million
Q3 2020

Nov 02, 2020

SELL
$146.22 - $169.13 $5.8 Million - $6.71 Million
-39,685 Reduced 22.72%
134,970 $20 Million
Q2 2020

Jul 31, 2020

SELL
$136.42 - $164.18 $13.8 Million - $16.6 Million
-101,300 Reduced 36.71%
174,655 $28.7 Million
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $49 Million - $60.6 Million
-411,279 Reduced 59.85%
275,955 $38.3 Million
Q1 2020

May 05, 2020

BUY
$119.05 - $147.35 $49.2 Million - $60.9 Million
413,564 Added 151.12%
687,234 $95.3 Million
Q4 2019

Jan 31, 2020

SELL
$106.92 - $132.43 $13.9 Million - $17.2 Million
-129,640 Reduced 32.14%
273,670 $36 Million
Q2 2019

Jul 30, 2019

BUY
$110.79 - $129.32 $322,398 - $376,321
2,910 Added 0.73%
403,310 $44.7 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $14.4 Million - $16.9 Million
-129,205 Reduced 24.4%
400,400 $52 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $5.79 Million - $6.64 Million
-76,445 Reduced 12.61%
529,605 $45.2 Million
Q2 2017

Aug 16, 2017

BUY
N/A
606,050
606,050 $49.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cullen Capital Management, LLC Portfolio

Follow Cullen Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cullen Capital Management, LLC with notifications on news.